Abstract-Studies suggest that GAD1 gene was a functional candidate susceptibility gene for cerebral palsy (CP). In order to investigate the contribution of GAD1 gene to the etiology of CP in Chinese infants, we car ried out a case-control association study between GAD1 gene and CP. In this study, 374 health controls and 392 infants with CP were recruited. Genomic DNA was extracted from venous blood and all three single nucleotide polymorphisms in GAD1 (rs3791874, rs3791862 and rs16858977) were genotyped by Sequenom's MassARRAY system. There were no significant differences in allele or genotype frequencies between CP or mixed CP patients and controls at any of the three genetic polymorphisms. Through haplotype analysis we found that haplotype GG (rs3791862, rs16858977) frequency demonstrated significantly statistical difference between mixed CP patients and controls (p = 0.0371). Our positive findings of haplotype GG suggested that variation of GAD1 gene was an important risk factor for mixed CP.
INTRODUCTION
Cerebral palsy (CP), which usually occurs in the developing fetal and infant, is defined as a non-pro gressive but not unchanging disorder of posture or movement resulting from an abnormality of the brain [1, 2] . The major clinical manifestations include spas tic diplegia, mental retardation, hyperreflexia, clumsi ness, unstable gait and drooling. Different individuals have some phenotypic variability, but spastic diplegia, and mental retardation are three constant traits pre sented in all affected individuals [3] . According to the overall clinical picture, CP can be classified into such subgroups as dyskinetic, ataxic, spastic and mixed CP [4, 5] . Approximately 2-3/1000 live births present with CP, which makes it one of the most common physical disability of childhood [6] . Although the aeti ology of CP has been attributed to a variety of factors, the detailed mechanisms underlying most cases remain elusive. Asphyxia, neuronal disorders, infec tions in utero, amnionitis, maternal autoimmune dis ease, metabolic disease, vascular lesions, as well as coagulation disorders all have been considered as risk factors for CP [7] . It is unknown that how the fetus responds in the presence of these risk factors and how 1 The article is published in the original. the genetic makeup influence the fetus response on the condition that some genotypes create susceptibility to cerebral damage. To date, a lot of case control studies have been carried out to investigate the association between genetic polymorphisms and CP. These studies have explored many genes, such as interleukin 6 (IL 6), apolipoprotein E (APOE), and cytokine, but the asso ciation between GAD1 and CP has not been investi gated [8] [9] [10] .
GAD1, 46 kb in length, with 17 exons, located in 2q31, codes for the 67 kDa isoform (GAD67) of L glutamate decarboxylase. GAD67 is one of the two major isoforms of GAD, an enzyme that converts glutamate to GABA. The other isoform, GAD65, is encoded by the gene GAD2. GAD67 exists as both homo-and heterodimers in both soluble and mem brane-bound forms, primarily within the cell soma but also to a limited degree in terminals [4, 11] . A great many of evidences indicated that GAD1 played more and more important role in nerve system disease such as autism and schizophrenia. Many studies on the association between GAD1 and nerve system diseases have been conducted and their results proved that the abruption of GAD1 gene was an important risk factor to the happening of schizophrenia, autism and child bipolar I disorder [11] [12] [13] [14] . There was also a study which demonstrated that GAD1 was associated with cortical gray matter volume loss in schizophrenia [15] . In addition, the linkage between GAD1 and cerebral palsy has been explored and the linkage region has been mapped to chromosome 2q24-25. A missense mutation in GAD67 was detected, which was segre gated with CP in affected individuals [4, 16] . However, whether the association between GAD1 and cerebral palsy in population exists has not been known yet. In order to investigate the association, we enrolled 374 health controls and 392 infants with CP. The associ ation analysis showed that no significant differences existed in allele or genotype frequencies between CP and controls. However, gene GAD1 with GG haplotype would more possibly increase the incidence of mixed CP. All subjects including CP patients and healthy controls belonged to Chinese Han population and written informed consent was asked from each subject. Symp toms of CP patients were assessed by a child neurolo gist with clinical examination or with medical records. This study was approved by the ethics committee of Zhengzhou University in accordance with the Hels inki declaration.
MATERIALS AND METHODS

Subjects
SNP selection. In this study, the SNP was selected according to the criterion of heterozygosity more than 15% and minor allele frequencies (MAF) more than 5%. A total of three SNPs were selected. Rs3791874 in intron 2 was selected because it was close to missense mutation (G36C) [4] . We consulted the HapMap database (release # 2, population: Han Chinese in Beijing) and selected tagging SNP rs3791862 in intron 3. In the middle part of gene GAD1 rs16858977 (intron 7) was selected since it could represent the largest block according to LD heat plot and CHB phased haplo types in HapMap database.
Genotyping. Genomic DNA was extracted from venous blood using AxyPrep Blood Genomic DNA Miniprep Kit (Axygen Biosciences, United States) and following the recommended procedure. SNP geno typing was performed using Sequenom's MassARRAY system (San Diego, United States) according to the manufacturers' specifications. Results were analyzed with Typer4.0 software (Sequenom). Those whose genotype results were analyzed were blind to the clini cal data.
Statistical analysis. We conducted Hardy-Wein berg equilibrium tests with Hardy-Weinberg test 3.0.xls, allele and genotype frequency, linkage disequi librium and haplotype analysis with the SHE-SIS soft ware. The haplotype blocks were defined as D' > 0.8. Linkage disequilibrium was measured using standard ized D' and r 2 , and the discrepancies in allele and gen otype frequencies on single locus between patients and controls were compared using a Fisher's exact test strategy. The numbers of observations for each haplo type were compared using x 2 tests between cerebral group and control group or between mixed cerebral palsy (MCP) sub-group and control. Correction of permutation test was applied to haplo-type analysis. All reported P values were two tailed and statistical significance was set at P < 0.05.
RESULTS
In this association study using 392 CP patients and 374 healthy controls, we tested three SNPs in GAD1 gene. The genotypic distribution of the three SNPs was in Hardy-Weinberg equilibrium in both the patient group (except rsl6858977 in MCP group) and the control group. Allele frequencies and genotypic distribution analysis of individual SNPs are shown in Table 1 . For the totality of the subjects, there were no significant differences of allele or genotype frequen cies between CP patients and controls at any of the three genetic polymorphisms. The similar results were observed between MCP and controls.
We investigated LD for all possible two-way com parisons among the three selected SNPs in GAD1. Analysis of D' revealed strong linkage disequilibrium (D' > 0.8) between rs3791874 and rs3791862 or between rs3791862 and rs16858977. However, no link age disequilibrium was observed between rs3791874 and rs16858977 (Table 2 ). Then we analyzed haplo type frequency in which rare haplotypes with a fre quency less than 0.03 were dropped. In total, four individual haplotypes were observed and three showed a frequency greater than 3%, among which no haplo type distribution produced positive results (Table 3) in CP group. In the exploratory analysis, where the sam ple was sub-grouped according to the clinical symp toms, significant evidence of preferential sharing of the haplotype GG in MCP subgroup (p = 0.0371) was compared with control group (Table 4) . aetiology of CP has been attributed to a variety of fac tors, the specific mechanism underlying most cases remains unknown. The efforts to reduce the incidence of perinatal brain injury in term infants have failed despite the improvement in obstetric and neonatal care [18, 19] . The genetic factors affecting CP have attracted more attention from researchers in recent years [20] [21] [22] . Many candidate genes have been found and identified as risk factors for CP. These candidate genes were categorized as cytokine, thrombophilic, apo lipoprotein E and a group related to cardiovascular dis ease or functions of immune system. But the association study on candidate gene such as GAD1 related to nervous system development hasn't been reported yet.
In the present study of Chinese infants, there were no significant differences of allele or genotype fre quencies between CP patients and controls at any of the three GAD1 gene polymorphisms. The results may be owing to these three SNPs are all located in intron and they are not functional variants of GAD1. Then we performed the haplotype analysis. The haplotype (rs3791874 and rs3791862) did not show any signifi cant difference between CP group and controls prob ably because the range from rs3791874 to rs3791862 did not cover any natural variant or contain any func tional region according to UniProt database. Thus we speculated that the haplotype (rs3791874 and rs3791862) probably did not alter the protein product of the gene and its catalytic activity. Similarly, the hap lotype (rs3791862 and rs16858977) did not show any significant difference between CP group and controls probably due to the occurrence of cerebral palsy attributed to a variety of risk factors. However, further analysis showed that the haplotype GG (rs3791862, rs16858977) distribution revealed a significant differ ence between mixed CP patients and controls. Linkage disequilibrium tests demonstrated a strong linkage dise quilibrium (D' > 0.8) between rs3791874 and rs3791862 or between rs3791862 and rs16858977. However, no marked linkage disequilibrium was found between rs3791874 and rs16858977. Given this, we supposed that rs3791862 was a newly formed SNP and might evolve because of gene-tic drift or positive Darwinian selection [23, 24] . According to this theory, the indi viduals with heterozygous status at rs3791862 should present a prominent linkage disequilibrium between rs3791874 and rs16858977 and our results verified the hypothesis (D' = 0.95). Based on this, the haplotype (rs3791874, rs3791862 and rs16858977) were analyzed and results showed that the haplotype TGG distribu tion revealed a significant difference between CP group and controls (p = 0.028) or between spastic quadriplegia CP group and controls (p = 0.0358) or between mixed CP group and controls (p = 0.0052) (data not shown). These results provided a positive support for the haplotype GG as a risk factor for the occurrence of mixed CP. The significant difference of haplotype GG between mixed CP patients and con trols was further supported by the genotype distribu tion in mixed CP group which displayed a prominent Hardy-Weinberg disequilibrium. In addition, the coverage area of selected SNPs added up to 64.23% in the whole GAD1 gene according to LD plot of CHB population in HapMap database. Based on these data, we speculated that gene GAD1 with haplotype GG should more possibly contribute to the occurrence of mixed CP.
There was a study documenting that 24% of term infants with CP had evidence of encepha-lopathy in the newborn period. Neonates with encephalopathy had significant deficits, memory impairment, visual dysfunction and increased hyperactivity. MCP is usu ally the spastic CP and the athetoid CP which com bine to cause many disabilities in a child. Generally mixed CP was more severely affected and more often had dysgnosia, cerebral visual impairment and dyski nesia [17, 25, 26] . In our study, the majority of patient samples, especially MCP, have one or more of the fol lowing features: dysnoesia, dysarthria, visual percep tive dysfunction and hearing impairment. Spastic quadriplegia was often associated with cortical and subcortical white matter damage or extensive necrosis in the brain [27] . Based on these facts, we could see that CP, especially mixed CP, was more often caused by the cerebral injury. The γ-aminobutyric acid (GABA) was synthesized by GAD67 in neurons and served as neurotransmitters/neuromodulators in the regulation of the circulation and permeability of the intrinsic microvessels within the central nervous sys tem (CNS) [28, 29] . Baclofen, as a GABA agonist, was used to reduce muscle tone in CP children and to decrease spasticity and furthermore, improvement in comfort and function were both observed. All these studies implied that GAD1 was involved in occurrence of CP. These facts were consistent with our findings that gene GAD1 was associated with the occurrence of CP, especially mixed CP. Gender related pathophysiological features are thought to be related to CP [30] . Therefore, we checked the gender differences in genetic susceptibil ity to CP, but found no association between the three GAD1 gene polymorphisms and CP. Prematurity is another important contributor to CP [31] . Gestation age differences with genetic susceptibility to CP were also compared in our study, but no difference was observed with respect to the GAD1 gene polymor phisms.
In conclusion, our results showed that none of the three SNPs in GAD1 contribute to the occurrence of CP in Chinese infants. However, gene GAD1 with GG haplotype is preferentially a risk factor for the occur rence of mixed CP. To our knowledge, this is the first report to demonstrate that GAD1 is associated with occurrence of mixed CP. Nonetheless, it should be stated that our findings are still preliminary and have many limitations such as fewer SNPs, small sample size of mixed CP and limited coverage field in the gene. Therefore, the further study is warranted.
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